Tokyo, Oct. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059394) titled 'Improving effects on blood lipids of Cuban sugarcane derived policosanol by oral administration: A systemic review and meta-analysis' on Oct. 16.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Fukuoka University
Condition:
Condition - Healthy adults with blood LDL cholesterol less than 140 mg/dL
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to investigate the improving effects on blood lipids of Cuban sugarcane derived policosanol by consecutive oral administration in healthy adults.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - PICOS:
Participant: Healthy adults with LDL-C<140mg/dL
Intervention: Consecutive oral intake of Cuban sugarcane derived policosanol
Comparison: Consecutive oral intake of Cuban sugarcane derived placebo
Outcome: Blood lipid parameters(LDL-C, TC, HDL-C, LDL-C/HDL-C ratio, TG)
Study design: Randomized placebo controlled trials (RCT), quasi-randomized placebo controlled trials (qRCT)
Key exclusion criteria - 1. Those that do not use blood LDL-C, TC, HDL-C, or TG as indicators
2. Those not derived from Cuban sugarcane-based policosanol
3. Those with an unknown amount of Cuban sugarcane-derived policosanol
4. Those combined with other ingredients (excluding those the other ingredients are shared with the placebo)
5. Those in which PICO cannot be assessed
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 08 Day
Anticipated trial start date - 2025 Year 08 Month 20 Day
Last follow-up date - 2025 Year 11 Month 27 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067931
Disclaimer: Curated by HT Syndication.
